boostAGErx Tirzepatide Review: Starting Price and Care Model

boostAGErx’s GLP-1 page advertises compounded tirzepatide starting at $145 per month, including the clinical review, plan, medication and shipping. The lower $95 headline belongs to semaglutide. It should not be used as a tirzepatide quote or assumed to describe an annual tirzepatide plan.³

Our assessment: the published starting price is useful, and the current site names the clinical organization and a dispensing pharmacy. The remaining decision is whether the selected payment schedule, supply and exit rules are clear enough before you commit.

Settle the billing unit before annualizing

The GLP-1 FAQ describes the tirzepatide rate as a starting monthly price and says it does not increase when the prescribed dose increases.³ That statement does not establish whether a particular purchase renews by calendar month or every 28 days, or what longer-plan commitment produces the starting figure.

Request the amount due immediately, recurring amount, exact next charge date and medication quantity together. Only use a 28-day billing cycle or an annual prepayment in your budget if those are the terms of your selected order. Multiplying a price by twelve is not a substitute for the payment schedule.

A four-week supply and a calendar month cover different periods. Ask whether refills are automatically submitted, whether a new clinical review is required and how a delayed refill affects renewal. If a longer plan is offered, compare its full upfront charge and cancellation rules with the shorter option.

The platform is separate from the care team

The homepage identifies White Label MD LLC / WLMD Network as the independent professional entities responsible for clinical evaluation, treatment planning and prescribing. It identifies Manifest Pharmacy in its fulfillment process. boostAGErx describes its own role as technology and administrative coordination.⁴

These names are more useful than a generic promise of licensed professionals, but confirm the actual clinician, practice and pharmacy facility assigned to you. Ask where treatment questions go, who reviews a refill and how to contact the dispensing pharmacist. A familiar platform brand does not answer each responsibility.

The company describes an online intake followed by clinician review and prescribing when appropriate.⁴ If you already use another program, provide the existing prescription and last-dose information rather than assuming you can continue an identical schedule. Approval, concentration and dispensing instructions must be resolved clinically.

Cancellation descriptions need an order-specific answer

The GLP-1 FAQ describes a full refund when the clinical team declines a prescription, a 14-day withdrawal period and no returns after compounded medication has shipped. The homepage more broadly permits cancellation requests before delivery and describes individual review after receipt.^3,4

Those descriptions should not be turned into a promise that every pre-delivery cancellation receives a refund. Ask whether an order already sent to the pharmacy can be stopped, which services are nonrefundable and what happens to an unused prepaid balance. Save the governing agreement rather than relying on a short homepage answer.

For an incorrect or damaged shipment, contact both support and the assigned pharmacist promptly. Keep the delivery record and follow the pharmacy’s instructions about storage and use. A delivery dispute, a clinician declining treatment and a change of mind are different situations.

How to judge the offer

Compounded preparations are not FDA-approved. The trials behind our tirzepatide evidence guide studied branded treatment, not a particular telehealth compound.^1,2 Read the compounding guide for product status. Discuss side effects, gallbladder concerns and the thyroid warning with your prescriber.

The advertised service may interest someone seeking an online cash-pay program, provided the written quote resolves the payment and cancellation questions. A named dispensing partner does not independently establish product quality, patient eligibility or availability in every state.

Compare the actual supply and renewal terms in our bmiMD review and Fitish review. Do not assume that similarly displayed monthly figures purchase equal periods or identical care. Our provider comparison gives wider context. This review concerns public information, not personal enrollment or observed treatment outcomes.